HAVCR2 and neoplasm: Intrinsic leukemic stem cells (LSCs) overexpress several immune checkpoint molecules, including PD-L1, TIM-3, and CD276, which not only suppress T-cell responses but also exert tumor-intrinsic effects that promote survival, proliferation, and stemness [155].